nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0708	0.0708	CbGpPWpGaD
Agomelatine—HTR2C—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0571	0.0571	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—UBE3A—cervical cancer	0.0473	0.0473	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—UBE3A—cervical cancer	0.0473	0.0473	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0431	0.0431	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0431	0.0431	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—TAAR6—cervical cancer	0.0328	0.0328	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—TAAR6—cervical cancer	0.0328	0.0328	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—WNT2—cervical cancer	0.0256	0.0256	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—WNT2—cervical cancer	0.0256	0.0256	CbGpPWpGaD
Agomelatine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0212	0.0212	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—WNT5A—cervical cancer	0.0194	0.0194	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—WNT5A—cervical cancer	0.0194	0.0194	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TAAR6—cervical cancer	0.0186	0.0186	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.0186	0.0186	CbGpPWpGaD
Agomelatine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0181	0.0181	CbGpPWpGaD
Agomelatine—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.0175	0.0175	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TAAR6—cervical cancer	0.0169	0.0169	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TAAR6—cervical cancer	0.0169	0.0169	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0139	0.0139	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—WNT2—cervical cancer	0.0132	0.0132	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—WNT2—cervical cancer	0.0132	0.0132	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.0127	0.0127	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AKAP13—cervical cancer	0.0127	0.0127	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AKAP13—cervical cancer	0.0115	0.0115	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AKAP13—cervical cancer	0.0115	0.0115	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0112	0.0112	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—TAAR6—cervical cancer	0.0106	0.0106	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—WNT5A—cervical cancer	0.00997	0.00997	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—WNT5A—cervical cancer	0.00997	0.00997	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TAAR6—cervical cancer	0.00996	0.00996	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TAAR6—cervical cancer	0.00996	0.00996	CbGpPWpGaD
Agomelatine—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00929	0.00929	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TAAR6—cervical cancer	0.00855	0.00855	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—WNT2—cervical cancer	0.00828	0.00828	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—WNT2—cervical cancer	0.00777	0.00777	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—WNT2—cervical cancer	0.00777	0.00777	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00773	0.00773	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—TP53—cervical cancer	0.00698	0.00698	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—TP53—cervical cancer	0.00698	0.00698	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKAP13—cervical cancer	0.00682	0.00682	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKAP13—cervical cancer	0.00682	0.00682	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—WNT2—cervical cancer	0.00668	0.00668	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—WNT5A—cervical cancer	0.00627	0.00627	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TAAR6—cervical cancer	0.00599	0.00599	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—WNT5A—cervical cancer	0.00589	0.00589	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—WNT5A—cervical cancer	0.00589	0.00589	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TAAR6—cervical cancer	0.00544	0.00544	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—WNT5A—cervical cancer	0.00506	0.00506	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TAAR6—cervical cancer	0.00483	0.00483	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TAAR6—cervical cancer	0.00439	0.00439	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—WNT2—cervical cancer	0.00425	0.00425	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00413	0.00413	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOTCH2—cervical cancer	0.00413	0.00413	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKAP13—cervical cancer	0.00411	0.00411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.00373	0.00373	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—WNT2—cervical cancer	0.00343	0.00343	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HES1—cervical cancer	0.00339	0.00339	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HES1—cervical cancer	0.00339	0.00339	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKAP13—cervical cancer	0.00331	0.00331	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.00322	0.00322	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.00321	0.00321	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.00307	0.00307	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00307	0.00307	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKAP13—cervical cancer	0.00301	0.00301	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TERT—cervical cancer	0.00297	0.00297	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TERT—cervical cancer	0.00297	0.00297	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—FGFR3—cervical cancer	0.00273	0.00273	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—FGFR3—cervical cancer	0.00273	0.00273	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.0026	0.0026	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.00259	0.00259	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOTCH1—cervical cancer	0.00256	0.00256	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOTCH1—cervical cancer	0.00256	0.00256	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00254	0.00254	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.00251	0.00251	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EGFR—cervical cancer	0.00228	0.00228	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EGFR—cervical cancer	0.00228	0.00228	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.0022	0.0022	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00205	0.00205	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.00202	0.00202	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MTOR—cervical cancer	0.00192	0.00192	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MTOR—cervical cancer	0.00192	0.00192	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.0019	0.0019	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.00178	0.00178	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CASP3—cervical cancer	0.00176	0.00176	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CASP3—cervical cancer	0.00176	0.00176	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CTNNB1—cervical cancer	0.0017	0.0017	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CTNNB1—cervical cancer	0.0017	0.0017	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.00153	0.00153	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—cervical cancer	0.00148	0.00148	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—cervical cancer	0.00148	0.00148	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—cervical cancer	0.00135	0.00135	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—cervical cancer	0.00135	0.00135	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.00133	0.00133	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA9—cervical cancer	0.00117	0.00117	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—cervical cancer	0.00113	0.00113	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—cervical cancer	0.00113	0.00113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES1—cervical cancer	0.00109	0.00109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.00108	0.00108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA9—cervical cancer	0.000997	0.000997	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000959	0.000959	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000883	0.000883	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.00088	0.00088	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000826	0.000826	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000773	0.000773	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000736	0.000736	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.00071	0.00071	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000666	0.000666	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.000619	0.000619	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000594	0.000594	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.000569	0.000569	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000549	0.000549	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000499	0.000499	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—cervical cancer	0.000478	0.000478	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—cervical cancer	0.000473	0.000473	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—cervical cancer	0.000459	0.000459	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	0.000443	0.000443	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—cervical cancer	0.000435	0.000435	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—cervical cancer	0.000405	0.000405	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—cervical cancer	0.000386	0.000386	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—cervical cancer	0.000365	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—cervical cancer	0.000351	0.000351	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—cervical cancer	0.000294	0.000294	CbGpPWpGaD
